Clinuvel Pharmaceuticals (CH:UR9)
CHF 4.07-0.23 (-5.41%)
CH:UR9
Clinuvel Pharmaceuticals earnings date
CHF 4.07
At close:-0.23 (-5.41%)
Clinuvel Pharmaceuticals (UR9) Q2 2024 Earnings Report
0 Followers
CH:UR9 Q2 2024 EPS Results
- Actual EPS
- CHF 0.12
- Consensus EPS
- CHF 0.15
- Beat/Miss
- Missed by -CHF 0.03
- One Year Ago EPS
- CHF 0.13
CH:UR9 Q2 2024 Revenue Results
- Actual Revenue
- CHF 18.39M
- Expected Revenue
- CHF 19.84M
- Beat/Miss
- Missed by -CHF 1.45M
- YoY Revenue Growth
- +9.89%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 02/21/2024
- Time
- After Close
- Conference Call
- Wednesday, February 21, 2024
CH:UR9 Upcoming Earnings
Clinuvel Pharmaceuticals 's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
CH:UR9 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:UR9 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2027 (Q2) | 0.14- | 0.12 | ― | ― |
| Aug 27, 2026 | 2026 (Q4) | 0.290.27 | 0.25 | 7.06% (+0.02) | |
| Feb 25, 2026 | 2026 (Q2) | 0.170.12 | 0.16 | -26.43% (-0.04) | |
| Aug 27, 2025 | 2025 (Q4) | 0.160.25 | 0.28 | -11.13% (-0.03) | |
| Feb 26, 2025 | 2025 (Q2) | 0.120.16 | 0.12 | 32.08% (+0.04) | |
| Aug 29, 2024 | 2024 (Q4) | 0.250.28 | 0.22 | 30.34% (+0.07) | |
| Feb 21, 2024 | 2024 (Q2) | 0.150.12 | 0.13 | -3.64% (-0.00) | |
| Aug 29, 2023 | 2023 (Q4) | 0.210.22 | 0.17 | 24.67% (+0.04) | |
| Feb 22, 2023 | 2023 (Q2) | 0.180.13 | 0.06 | 92.98% (+0.06) | |
| Aug 30, 2022 | 2022 (Q4) | 0.250.17 | 0.2 | -14.85% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

